Systematic Review and Meta-analysis of Olfactory and Gustatory Dysfunction in COVID-19
Overview
Affiliations
Background: Chemosensory disorders associated with COVID-19 have been widely discussed during the pandemic. We performed a meta-analysis to assess the risk factors for olfactory and gustatory dysfunction in patients with COVID-19.
Methods: Three databases (PubMed, Embase, and Cochrane Library) were searched for studies published between December 1, 2019, and August 31, 2021. We selected random-effects model or fixed-effects model to pool data based on heterogeneity. The results were reported as odds ratios (ORs) or standardized mean differences (SMDs) and the corresponding 95% confidence intervals (CIs). Heterogeneity was reported as I.
Results: Twenty-six studies with a total of 13,813 patients were included. The pooled data indicated that sex (OR 1.47; 95% CI 0.93-2.31), age (SMD -5.80; 95% CI -13.35 to 1.75), smoking (OR 2.04; 95% CI 0.72-5.79), and comorbidity (OR 1.21; 95% CI 0.58-2.53) of patients with COVID-19 had no effect on gustatory dysfunction. Olfactory dysfunction was more likely to occur in older patients with COVID-19 (SMD, -5.22; 95% CI, -8.28 to -2.16). Patients with COVID-19 with nasal congestion (OR 3.41; 95% CI 2.30-5.06) and rhinorrhea (OR 2.35; 95% CI 1.60-3.45) were more prone to olfactory dysfunction.
Conclusion: These findings emphasize that older patients with COVID-19 are more likely to experience olfactory dysfunction. Symptoms of nasal congestion and rhinorrhea may affect the recognition of olfactory dysfunction.
Post COVID-19 and Long COVID Symptoms in Otorhinolaryngology-A Narrative Review.
Guntinas-Lichius O, Bitter T, Takes R, Lee V, Saba N, Makitie A J Clin Med. 2025; 14(2).
PMID: 39860512 PMC: 11765628. DOI: 10.3390/jcm14020506.
Coppin G, Onofrio M Cogn Process. 2024; 26(1):231-234.
PMID: 39400658 PMC: 11897111. DOI: 10.1007/s10339-024-01235-8.
Mapping the vast landscape of multisystem complications of COVID-19: Bibliometric analysis.
Zhu Y, Cao X, Ying R, Liu K, Chai Y, Luo M Heliyon. 2024; 10(9):e30760.
PMID: 38765136 PMC: 11098853. DOI: 10.1016/j.heliyon.2024.e30760.
Integrating the patient's voice into the research agenda for treatment of chemosensory disorders.
Murphy C, Dalton P, Boateng K, Hunter S, Silberman P, Trachtman J Chem Senses. 2024; 49.
PMID: 38761171 PMC: 11154145. DOI: 10.1093/chemse/bjae020.
Long-Term Taste and Smell Outcomes After COVID-19.
Sharetts R, Moein S, Khan R, Doty R JAMA Netw Open. 2024; 7(4):e247818.
PMID: 38652477 PMC: 11040410. DOI: 10.1001/jamanetworkopen.2024.7818.